News

Deal Announcements

Intersect ENT Lands $30 Million New Venture Capital

Wednesday, November 3, 2010 5:51:00 AM PDT | VentureDeal Staff
Palo Alto, California  --  Medical device company Intersect ENT (formerly Sinexus) has garnered $30 million in its third round of institutional venture capital funding.

Intersect ENT is developing new therapies for Ear, Nose & Throat surgeons.

Investors in the round included Medtronic, PTV Sciences, Kleiner Perkins Caufield & Byers and US Venture Partners. The company said it would use the funding proceeds to commercialize its first product and to build a portfolio of additional products.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1